FDA.reportPublic FDA data

TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet

RxCUI
285028
RxNorm name
TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet
Display name
TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet
Full name
TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3354e50f-4dc5-413f-b5ae-87353ab8913dTRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet [PSN] · abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir] [SBD] · abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet [Trizivir] [SY] · Trizivir (abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG) Oral Tablet [SY]42These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 200020140424